Axcelis Technologies, Inc. ACLS
123.11
6.97
6.00%
as of 25 Sep
- Market cap
- $3.6B
- P/E
- 41.0×
Follow ACLS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.97 | 21.03 | 28.82 | 63.15 |
P/S ratio |
3.58 | 3.02 | 3.38 | 6.74 | |
P/FCF ratio |
24.63 | 23.70 | 32.32 | 89.03 | |
P/Operating CF |
67.36 | (386.27) | 157.65 | 317.64 | |
P/B ratio |
2.99 | 2.45 | 2.74 | 5.48 | |
Price to Tangible BV |
2.99 | 2.45 | 2.74 | 5.48 | |
EV/Sales |
3.12 | 2.64 | 3.01 | 6.34 | |
EV/EBITDA |
17.80 | 16.70 | 22.68 | 52.69 | |
EV/Operating CF |
19.33 | 18.75 | 26.36 | 72.89 | |
EV/FCF |
21.45 | 20.72 | 28.80 | 83.72 | |
Quick Ratio |
3.00 | 2.75 | 2.59 | 2.78 | |
Current Ratio |
4.95 | 4.77 | 4.59 | 4.90 | |
Net Debt/EBITDA |
(14.45) | (8.38) | (26.26) | (15.32) | |
Debt/Assets |
3.04% | 2.99% | 2.93% | 2.87% | |
Debt/Equity |
0.04 | 0.04 | 0.04 | 0.04 | |
Asset Turnover |
0.63 | 0.62 | 0.62 | 0.64 | |
Operating CF/Net income |
1.75 | (0.19) | 1.97 | 0.79 | |
Capex/Depreciation |
(0.62) | (0.64) | (0.41) | (1.05) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11.53% | 12.64% | 14.33% | 13.47% | |
Selling, General and Administrative Expense of Revenue |
18.33% | 19.15% | 22.17% | 19.49% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.50% | 2.14% | 2.46% | 2.99% | |
Graham Net Nets |
0.21 | 0.24 | 0.21 | 0.11 | |
Graham Number |
55.84 | 53.07 | 49.71 | 48.33 | |
Earnings Yield |
4.35% | 4.75% | 3.47% | 1.58% | |
Free Cash Flow Yield |
4.06% | 4.22% | 3.09% | 1.12% | |
Revenue per Share |
6.83 | 7.55 | 6.48 | 6.99 | |
Operating CF per Share |
1.45 | (0.21) | 0.59 | 0.60 | |
Capex per Share |
(0.06) | (0.07) | (0.06) | (0.12) | |
Free Cash Flow per Share |
1.39 | (0.28) | 0.53 | 0.48 | |
Cash per Share |
14.37 | 11.85 | 11.93 | 13.06 | |
Shareholders Equity per Share |
32.61 | 32.77 | 34.00 | 34.60 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.61 | 32.77 | 34.00 | 34.60 | |
Free Cash Flow |
43.34 | (8.90) | 16.30 | 14.82 | |
Working Capital |
785.04 | 745.54 | 731.77 | 779.67 | |
Capital Expenditures |
(2.01) | (2.33) | (1.84) | (3.55) | |
Net Current Asset Value |
652.23 | 616.53 | 605.78 | 658.75 | |
EV/EBIT |
19.33 | 18.59 | 25.97 | 61.37 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
12.17% | 14.39% | 4.63% | 10.82% | |
Price to Operating Income |
22.19 | 21.26 | 29.15 | 65.26 | |
| Other line items | |||||
Average Receivables |
165.59 | 185.81 | 163.38 | 146.50 | |
Average Payables |
53.26 | 44.62 | 45.27 | 47.96 | |
Average Inventory |
307.65 | 305.62 | 310.95 | 324.47 | |
Average Assets |
1,345.03 | 1,355.07 | 1,357.58 | 1,355.16 | |
Average Common Equity |
997.87 | 1,023.73 | 1,035.94 | 1,044.10 |
Columns are period end dates